VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (3)
A 1-year lifestyle intervention for weight loss in individuals with type 2 diabetes reduces high C-reactive protein levels and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) study.
Identification of a ?-lactamase inhibitory protein variant that is a potent inhibitor of Staphylococcus PC1 ?-lactamase.
The KRAS-variant is associated with risk of developing double primary breast and ovarian cancer.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The KRAS-variant is associated with risk of developing double primary breast and ovarian cancer.
The KRAS-variant is associated with risk of developing double primary breast and ovarian cancer. PLoS One. 2012; 7(5):e37891.
View in:
PubMed
subject areas
Adult
Aged
Breast Neoplasms
Female
Genes, BRCA1
Genes, BRCA2
Genes, ras
Genetic Variation
Humans
Middle Aged
Mutation
Neoplasms, Multiple Primary
Ovarian Neoplasms
Prevalence
Risk
authors with profiles
XIFENG WU
MICHELLE A.T. HILDEBRANDT